CRB2
protein-codingcrumbs cell polarity complex component 2, the group of Crumbs complex
Gene summary
This gene encodes a member of a family of proteins that are components of the Crumbs cell polarity complex. In mammals, members of this family are thought to play a role in many cellular processes in early embryonic development. A similar protein in Drosophila determines apicobasal polarity in embryonic epithelial cells. Mutations in this gene are associated with focal segmental glomerulosclerosis 9, and with ventriculomegaly with cystic kidney disease. [provided by RefSeq, Aug 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009063
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009063
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009063
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014539
Submitter: ClinGen
The *CRB2* gene is located on chromosome 9 at q33.3 and encodes the crumbs cell polarity complex component 2 protein which plays a role in many cellular processes in early embryonic development, including: epithelial-to-mesenchymal transition at gastrulation, when mesodermal cells move inside the embryo; apical polarity complex maintenance in the cerebral cortex, in the retina and in photoreceptor polarity; and interacts with nephrin in slit diaphragm. *CRB2* mutation was first reported in relation to familial idiopathic steroid resistant nephrotic syndrome (also known as focal segmental glomerulosclerosis 9; FSGS9) by Ebarasi (2015; PMID: 25557779) and with ventriculomegaly with cystic kidney disease by Slavotinek (2015, PMID: 25557780). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in the molecular mechanism or inheritance pattern and noted phenotypic overlap. Therefore, the following disease entities have been lumped into one disease entity, FSGS9 (OMIM:616220) and ventriculomegaly with cystic kidney disease (OMIM:219730). The preferred disease name suggested for this grouping of disorders is ‘Glomerulopathy, with or without ventriculomegaly and renal cysts - CRB2’. Many variants have been reported in *CRB2* including mainly null variants, but also missense changes, and the maximum score for genetic evidence was reached (12 pts). The mechanism of pathogenicity is loss of function. This gene-disease association is also supported by expression studies, protein interaction data, and a non-human model organism. In summary *CRB2* is definitively associated with Glomerulopathy, with or without ventriculomegaly and renal cysts - CRB2. This has been demonstrated in both the research and clinical diagnostic setting, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0019200
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0019006
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014539
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic; Renal
Intervention: Renal
Rationale: The condition can involve steroid-resistant nephrotic syndrome, and early diagnosis may allow early and more specific management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CRB2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_173689.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 215 | 4 | 225 | ||
| missense | 3 | 13 | 374 | 74 | 464 | |
| nonsense | 11 | 6 | 17 | |||
| start loss | 1 | 1 | ||||
| frameshift | 13 | 15 | 4 | 32 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 28 | 35 | 385 | 289 | 4 | 741 |
Highest pathogenic variant AF is 0.0016079978
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_775960.4 | 13 | MANE Select | |
| Ensembl | ENSP00000362734.3 | 13 | MANE Select | |
| Ensembl | ENSP00000353092.3 | 10 | Standard | |
| Ensembl | ENSP00000435279.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| crb2a | Danio rerio | Structure: cardiac muscle cell Quality: structure abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Hippo signaling pathway - Homo sapiens (human)
Biological Process
- mesoderm formation
- somitogenesis
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- regulation of gastrulation
- positive regulation of epithelial to mesenchymal transition
Molecular Function
- calcium ion binding
- aspartic-type endopeptidase inhibitor activity
- protein-containing complex binding
Cellular Component
- plasma membrane
- integral component of membrane
- apical plasma membrane
- protein-containing complex
- membrane raft
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373631
- Coding exons
- 13
- Length
- 24155
- Individuals with no LoFs
- 125666
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 81
- Defined
- 125747
- p
- 0.000322
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.11 | 662 | 747 | 0.886 | 0.0000482 | 7989 |
| Missense (PolyPhen) | 67 | 82.694 | 0.81022 | 830 | ||
| Synonymous | -0.252 | 353 | 347 | 1.02 | 0.0000250 | 2811 |
| Loss of Function | 2.16 | 29 | 44.5 | 0.651 | 0.00000237 | 470 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000063 | 0.000062 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00036 | 0.00035 | rare |
| South Asian | 0.00063 | 0.00062 | rare |
| Other | 0.00050 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Apical polarity protein that plays a central role during the epithelial-to-mesenchymal transition (EMT) at gastrulation, when newly specified mesodermal cells move inside the embryo. Acts by promoting cell ingression, the process by which cells leave the epithelial epiblast and move inside the embryo to form a new tissue layer. The anisotropic distribution of CRB2 and MYH10/myosin-IIB at cell edges define which cells will ingress: cells with high apical CRB2 are probably extruded from the epiblast by neighboring cells with high levels of apical MYH10/myosin-IIB. Also required for maintenance of the apical polarity complex during development of the cortex. {ECO:0000250|UniProtKB:Q80YA8}.;
- Disease
- DISEASE: Focal segmental glomerulosclerosis 9 (FSGS9) [MIM:616220]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:25557779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventriculomegaly with cystic kidney disease (VMCKD) [MIM:219730]: A severe autosomal recessive developmental disorder manifesting in utero. It is characterized by cerebral ventriculomegaly, echogenic kidneys, microscopic renal tubular cysts and findings of congenital nephrosis. {ECO:0000269|PubMed:25557780}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.103
- RVIS EVS
- 0.1
- RVIS percentile EVS
- 61.28
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.807
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |